SCHEMBL19417892

SCHEMBL19417892

O=Nc1cc(F)ccc1NC(=O)CCl

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.46
▸ HTT P42858 2/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ KMT2A Q03164 3/20 0.43
▸ MAPT P10636 3/20 0.41
▸ RAB9A P51151 2/20 0.40
▸ POLB P06746 2/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ MITF O75030 1/20 0.40
▸ THRB P10828 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ TDP1 Q9NUW8 2/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ AR P10275 1/20 0.38
▸ PKM P14618 1/20 0.38
▸ HDAC3 O15379 1/20 0.37
▸ HDAC1 Q13547 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30986310 0.80 RAB9A (0.59) ALDH1A1HTTSMN1; SMN2KMT2ARAB9A
SCHEMBL263278 0.80 RAB9A (0.59) ALDH1A1HTTSMN1; SMN2KMT2ARAB9A
SCHEMBL30342248 0.79 KMT2A (0.64) ALDH1A1HTTSMN1; SMN2KMT2AMAPT
SCHEMBL10951824 0.79 KMT2A (0.64) ALDH1A1HTTSMN1; SMN2KMT2AMAPT
SCHEMBL9846829 0.79 HDAC3 (0.51) ALDH1A1HTTSMN1; SMN2KMT2AMAPT
SCHEMBL27817210 0.78 ALDH1A1 (0.49) ALDH1A1HTTSMN1; SMN2KMT2AMAPT
SCHEMBL29678316 0.78 ALDH1A1 (0.51) ALDH1A1HTTSMN1; SMN2KMT2AMAPT
SCHEMBL5913136 0.78 ALDH1A1 (0.51) ALDH1A1HTTSMN1; SMN2KMT2AMAPT
SCHEMBL1946930 0.78 ALDH1A1 (0.71) ALDH1A1HTTSMN1; SMN2KMT2AMAPT
SCHEMBL13652566 0.77 POLB (0.59) ALDH1A1HTTSMN1; SMN2KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2925757-B1 COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES NOVARTIS AG (CH) 2017-10-04 — — EP disclosed
Send feedback